Quantum Biopharma (NASDAQ:QNTM) Trading Down 3% – Here’s What Happened

Quantum Biopharma Ltd. (NASDAQ:QNTM) shares were down 3% during trading on Tuesday . The stock traded as low as $3.20 and last traded at $3.28. Approximately 38,874 shares traded hands during trading, a decline of 45% from the average daily volume of 70,708 shares. The stock had previously closed at $3.38.

Quantum Biopharma Price Performance

The firm has a market cap of $6.29 million, a PE ratio of -0.21 and a beta of 0.60. The business has a 50 day simple moving average of $4.30.

Institutional Trading of Quantum Biopharma

An institutional investor recently bought a new position in Quantum Biopharma stock. Virtu Financial LLC acquired a new position in shares of Quantum Biopharma Ltd. (NASDAQ:QNTM) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 11,428 shares of the company’s stock, valued at approximately $46,000. Virtu Financial LLC owned about 0.60% of Quantum Biopharma at the end of the most recent reporting period. 1.24% of the stock is currently owned by institutional investors.

Quantum Biopharma Company Profile

Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments.